You are here: Home > Institute of Excellence (CPD) > CPD Events > PDR: A New Anti-VEGF Era?

PDR: A New Anti-VEGF Era?

Available from: 11/12/2018

Where to publish: and

Provider: Mivision

Contact: Nikki Byrne, [E], [P] 02 8336 8616

Learning Objectives

  • How to diagnose proliferative diabetic retinopathy
  • The prevalence and epidemiology of proliferative diabetic retinopathy
  • The risk factors for proliferative diabetic retinopathy
  • The clinical features of proliferative diabetic retinopathy and that this is an eye-threatening disease
  • Ocular and systemic investigations required for proliferative diabetic retinopathy. Ocular investigations to be discussed include: optical coherence tomography, fluorescein angiography and OCT-angiography.
  • That both ocular and systemic management is required for the treatment of proliferative diabetic retinopathy. That the mainstay of ocular management is panretinal photocoagulation, although intra-vitreal anti-VEGF therapy may also have a role.
  • The indications for performing vitrectomy surgery in patients with proliferative diabetic retinopathy

Max points awarded: 2.00

Session Information

PDR: A New Anti-VEGF Era?
Activity Type
Independent Learning with Assessment
Points for attending & Passing Assessment

NameActivity TypeTherapeutic?Manufacturer/
Points for attending &
Passing Assessment
PDR: A New Anti-VEGF Era?Independent Learning with AssessmentNoNo2.00